Citation Tools
EBM analysis
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps